Abstract
Marrow transplantation is a method to reduce the hematological toxicity of ablative cytotoxic therapy; the immunologic problems of allogeneic marrow transplantation are avoided by using syngeneic marrow. Because identical twinning is rare, syngeneic marrow transplantation can be of chief benefit as an idealized model for autologous transplantation, a marrow source of ready availablity. The primary problem associated with syngeneic marrow transplantation for treating malignancy is not related to the marrow per se, but to the inability of the pretransplant ablative regimens to eradicate advanced cancer (1). Therefore the reinoculation of malignant cells in the autologous marrow, although worrisome, is of lesser immediate concern. Nevertheless, efforts to purge the marrow of tumor cells are important, and these efforts should parallel improvements in ablative regimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buckner CD, Stewart PS, Bensinger W, et al. Critical issues in autologous marrow transplantation for hematological malignancies. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R. Liss Inc, 1983: 599–614.
Frei E, Canellos GP. Dose: A critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–94.
Fefer A, Cheever MA, Thomas ED, et al. Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood 1981; 57: 421–30.
Appelbaum FR, Fefer A, Cheever MA, et al. Treatment of non-Hodgkin’s lymphoma with marrow transplantation in identical twins. Blood 1981; 58: 509–13.
Herzig GP. Autologous marrow transplantation in cancer therapy. Prog Hematol 1981; 12: 1–23.
Phillips GL, Fay JW, Herzig GP, et al. Intensive BCNU and cryopreserved autologous marrow transplantation for refractory cancer: A Phase I-II study. Cancer 1983; 52: 1792–1802.
Buckner CD, Rudolph RH, Fefer A, et al. High-dose cyclophosphamide therapy for malignant disease. Cancer 1972; 29: 357–65.
Appelbaum FR, Thoma ED. Review of the use of marrow transplantation in the treatment of non-Hodgkins’ lymphoma. J Clin Oncol 1983; 1: 440–7.
Lazarus HM, Gottfried MR, Herzig RH, et al. Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation. Cancer 1982; 49: 1789–95.
Lazarus HM, Herzig RG, Graham-Pole J, et al. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol 1983; 1: 359–67.
Wolff SN, Fer MF, McKay CM, et al. High-dose VP16-213 and autologous bone marrow transplantation for refractory malignancy: A Phase I study. J Clin Oncol 1983; 1: 701–6.
Appelbaum FR, Herzig GP, Graw RG, et al. Accelerated hemopoietic recovery following the infusion of cryopreserved autologous bone marrow in patients with lymphoma. Exp Hematol 1979; 7 (suppl 5): 297–301.
Peters LJ, Withers HR, Condiss JH, et al. Radiobiological considerations in the use of total body irradiation for bone marrow transplantation. Radiol 1979; 131: 243–7.
Burnett AK, Tansey P, Hills L, et al. Hematological reconstitution following high-dose and supralethal chemo-radiotherapy using stored non- cryopreserved autologous bone marrow. Brit J Haemol 1983; 54: 309–16.
Buckner CD, Appelbaum FR, Thomas ED. Bone marrow and fetal liver. In: Karow AM, Pegg DE, eds. Organ preservation for transplantation. New York and Basel: Marcel Dekker Inc, 1981: 355–426.
Phillips GL, Herzig RH, Lazarus HM, et al. Treatment of malignant lymphoma in relapse with cyclophosphamide, total body irradiation and cryopreserved autologous marrow transplantation. N Engl J Med 1984, in press.
Thomas ED. Marrow transplantation for malignant disease. J Clin Oncol 1983; 1: 517–31.
Hansen JA, Clift RA, Beatty PG, et al. Marrow transplantation from donors other than HLA genotypically identical siblings. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 739–56.
Powles RL, Morgenstein GR, Crofts M, et al. Mismatched family bone marrow transplantation. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 757–68.
Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts in HLA-identical siblings. N Engl J Med 1983; 308: 302–7.
Starke ID, Thein SL, Goldman JM, et al. Graft-versus-host disease after treatment for chronic granulocytic leukemic in transformation. Brit J Haematol 1982; 52: 383–7.
Appelbaum FR, Meyers JD, Fefer A, et al. Non-bacterial, non-fungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 1982; 33: 265–8.
Weiden PL, Flournoy N, Sanders TE, et al. Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc 1981; 13: 248–51.
Benjamin D, Magrath IT, Douglas EC, Corash LM. Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphoma: Evidence of occult bone marrow involvement. Blood 1983; 61: 1017–9.
Phillips GL. Current and clinical trials with intensive therapy and autologous bone marrow transplantation for lymphomas and solid tumors. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 567–97.
Dicke KA. Purging of marrow cell suspensions. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 679–88.
Zander AR, Dicke KA, Vellekoop L, et al. Autografting in acute leukemia. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 689–702.
Herzig RH, Phillips GL, Lazarus HM, et al. Autologous bone marrow transplantation in the treatment of hematological malignancies. In: Wernick Ph, ed. Neoplastic diseases of the blood and blood forming organs. New York, Churchill Livingston, 1984 (in press).
Fefer A, Cheever MA, Greenberg PD, et al. Bone marrow transplantation (BMT) for acute leukemia with identical twins: Improved results with BMT in complete remission. Proc Asco 1983; 19: 182.
Kaye SB. Intensive chemotherapy for solid tumor - current clinical applications. Can Chemother Pharmacol 1982; 9: 123–33.
Spitzer G, Zander A, Tannir P, et al. Autologous bone marrow transplantation in human solid tumors. In: Gale RP, ed. Recent advances in bone marrow transplantation. Alan R Liss, Inc, New York 1983: 615–42.
Herzig RH, Lazarus HM, Graham-Pole J, et al. Autologous bone marrow transplantation for malignant diseases: A Phase I-II study for melanoma, neuroblastoma, Ewing’s sarcoma and germ cell tumors using high-dose melphalan. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R Liss Inc, 1983: 643–57.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Phillips, G.L. (1984). The Role of Autologous Bone Marrow Transplantation in Cancer Treatment. In: Smit Sibinga, C.T., Das, P.C., Opelz, G. (eds) Transplantation and Blood Transfusion. Developments in Hematology and Immunology, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3840-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3840-6_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3842-0
Online ISBN: 978-1-4613-3840-6
eBook Packages: Springer Book Archive